J9394 Injection, fulvestrant (fresenius)
J-Codes
Also known as: fulvestrant, Faslodex
Injection of fulvestrant from Fresenius manufacturer. Estrogen receptor antagonist for metastatic breast cancer.
Clinical Context
Fresenius manufactured fulvestrant for estrogen receptor-positive metastatic breast cancer treatment.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.